ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Healthcare IT Infectious Respiratory Disease Diagnostics Market Size, Demand, Forecast to 2031
Infectious Respiratory Disease Diagnostics Market

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Swabs, Blood, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other technologies), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Other Respiratory Disease Testing), By End-Use (Hospitals, Diagnostic Laboratories, Physician Offices, Other End Users) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55441DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Infectious Respiratory Disease Diagnostics Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    7. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Saliva
          1. By Value
        3. Nasopharyngeal Swabs (NPS)
          1. By Value
        4. Anterior Nasal Swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassay
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Microbiology
          1. By Value
        5. Other technologies
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. COVID-19
          1. By Value
        3. Influenza
          1. By Value
        4. Respiratory Syncytial Virus (RSV)
          1. By Value
        5. Tuberculosis
          1. By Value
        6. Streptococcus Testing
          1. By Value
        7. Other Respiratory Disease Testing
          1. By Value
      5. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Hospitals
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Physician Offices
          1. By Value
        5. Other End Users
          1. By Value
    8. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    7. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Saliva
          1. By Value
        3. Nasopharyngeal Swabs (NPS)
          1. By Value
        4. Anterior Nasal Swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassay
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Microbiology
          1. By Value
        5. Other technologies
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. COVID-19
          1. By Value
        3. Influenza
          1. By Value
        4. Respiratory Syncytial Virus (RSV)
          1. By Value
        5. Tuberculosis
          1. By Value
        6. Streptococcus Testing
          1. By Value
        7. Other Respiratory Disease Testing
          1. By Value
      5. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Hospitals
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Physician Offices
          1. By Value
        5. Other End Users
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    7. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Saliva
          1. By Value
        3. Nasopharyngeal Swabs (NPS)
          1. By Value
        4. Anterior Nasal Swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassay
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Microbiology
          1. By Value
        5. Other technologies
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. COVID-19
          1. By Value
        3. Influenza
          1. By Value
        4. Respiratory Syncytial Virus (RSV)
          1. By Value
        5. Tuberculosis
          1. By Value
        6. Streptococcus Testing
          1. By Value
        7. Other Respiratory Disease Testing
          1. By Value
      5. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Hospitals
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Physician Offices
          1. By Value
        5. Other End Users
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Singapore
    13. Taiwan
    14. South East Asia
    15. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    7. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Saliva
          1. By Value
        3. Nasopharyngeal Swabs (NPS)
          1. By Value
        4. Anterior Nasal Swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassay
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Microbiology
          1. By Value
        5. Other technologies
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. COVID-19
          1. By Value
        3. Influenza
          1. By Value
        4. Respiratory Syncytial Virus (RSV)
          1. By Value
        5. Tuberculosis
          1. By Value
        6. Streptococcus Testing
          1. By Value
        7. Other Respiratory Disease Testing
          1. By Value
      5. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Hospitals
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Physician Offices
          1. By Value
        5. Other End Users
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Saliva
        1. By Value
      3. Nasopharyngeal Swabs (NPS)
        1. By Value
      4. Anterior Nasal Swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Immunoassay
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Microbiology
        1. By Value
      5. Other technologies
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. COVID-19
        1. By Value
      3. Influenza
        1. By Value
      4. Respiratory Syncytial Virus (RSV)
        1. By Value
      5. Tuberculosis
        1. By Value
      6. Streptococcus Testing
        1. By Value
      7. Other Respiratory Disease Testing
        1. By Value
    6. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Hospitals
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Physician Offices
        1. By Value
      5. Other End Users
        1. By Value
    7. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Saliva
          1. By Value
        3. Nasopharyngeal Swabs (NPS)
          1. By Value
        4. Anterior Nasal Swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Immunoassay
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Microbiology
          1. By Value
        5. Other technologies
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. COVID-19
          1. By Value
        3. Influenza
          1. By Value
        4. Respiratory Syncytial Virus (RSV)
          1. By Value
        5. Tuberculosis
          1. By Value
        6. Streptococcus Testing
          1. By Value
        7. Other Respiratory Disease Testing
          1. By Value
      5. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Hospitals
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Physician Offices
          1. By Value
        5. Other End Users
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Infectious Respiratory Disease Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Koninklijke Philips N.V.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. NIHON KOHDEN CORPORATION
    3. Thermos Fisher Scientific Inc.
    4. Cardinal Health
    5. F. Hoffmann-La Roche AG.
    6. COSMED
    7. Abbott Laboratories, Becton
    8. Dickinson and Company
    9. Smiths Group plc
    10. Alere, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Infectious Disease Diagnostics Market Size The global infectious disease diagnostics market size was valued at USD 22.85 billion in 2024 and is projected to reach from USD 24.65 billion in 2025 to USD 45.22 billion by 2033,
Buy Now
Global Report
Veterinary Infectious Disease Diagnostics Market Size The global veterinary infectious disease diagnostics market size was valued at USD 2.27 billion in 2024 and is expected to grow from USD 2.46 billion in 2025 to USD 4.73 billi
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.